Results from Co-IP and immunofluorescence staining revealed that the ubiquitination of Cx43 was involved in depression-inflammation disease, while Rg1 treatment declined the ubiquitination of Cx43 to alleviate depression and inflammation in vivo. Here, GJA1 is linked to depressive symptom measurement.